Salmeterol in smokers with COPD

Lipworth, B. J.
January 1996
Thorax;Jan1996, Vol. 51 Issue 1, p110
Academic Journal
No abstract available.


Related Articles

  • Chronic Obstructive Pulmonary Disease.  // Current Medical Literature: Respiratory Medicine;2008, Vol. 22 Issue 4, p105 

    The article presents abstracts related to chronic obstructive pulmonary diseases (COPD) which includes the effects of salmeterol and flutiscasone propionate on COPD patients, the use of mucolytic agents as a treatment for COPD and the two main treatment options for COPD.

  • Depression, COPD and compliance. Newson, Louise // GP: General Practitioner;4/14/2006, p23 

    This article presents information on several medical research conducted in Great Britain. Perindopril reduces by 38 per cent the combined risk of death, cardiac remodelling and hospitalisation for heart failure in elderly patients who have had a myocardial infarction, according to a study. A...

  • Efficacy of Inhaled Fluticasone Plus Salmeterol in COPD. Miller, Karl E. // American Family Physician;5/1/2004, Vol. 69 Issue 9, p2239 

    Deals with the findings of a study on the efficacy of fluticasone propionate and salmeterol in patients with chronic obstructive pulmonary disease (COPD). Use of bronchodilators as first-line therapy treatment for COPD; Effect of inhaled corticosteroids in patients with COPD; Effectiveness of...

  • Best Combination Therapy for Symptomatic Relief in COPD.  // OB/GYN Clinical Alert;Oct2008 Clinical Briefs in Primary, p20 

    The article focuses on a study that discovers the best combination therapy for symptomatic relief in chronic obstructive pulmonary disease (COPD). The study evaluates the patients with moderates COPD to receive six weeks of either tiotropium + formoterol or salmeterol + fluticasone. It was found...

  • Tiotropium more effective than salmeterol in preventing exacerbations of COPD.  // Australian Journal of Pharmacy;Sep2011, Vol. 92 Issue 1096, p102 

    The article presents a study to find whether tiotropium is more effective than salmeterol in preventing exacerbations of chronic obstructive pulmonary disease (COPD).

  • Indacaterol the dominant option for COPD in Germany.  // PharmacoEconomics & Outcomes News;8/20/2011, Issue 635, p6 

    The article discusses a study which compared the cost effectiveness of indacaterol with tiotropium bromide and salmeterol in treating patients with chronic obstructive pulmonary disease (COPD) in Germany.

  • Ipratropium bromide is more effective than Salmeterol - Fluticason combination on O2 saturation patients with COPD. Rezaie, Nader; Sadat Shams-Hosseini, Narges; Kashanizadeh, Atefeh; Karimi, Mohammad Ali // Journal of Research in Medical Sciences;Aug2013, Vol. 18 Issue 8, p731 

    A letter to the editor is presented on a study investigating the effectiveness of Ipratropium bromide and Salmeterol Fluticason (SFC) in chronic obstructive pulmonary disease (COPD) patients.

  • Salmeterol and Cardiovascular Events in Patients with COPD. Miller, Karl E. // American Family Physician;2/1/2004, Vol. 69 Issue 3, p704 

    Discusses the study "Cardiovascular Safety in Salmeterol in COPD," by G.T. Ferguson et al., from the June 2003 issue of the journal "Chest."

  • Airway gene expression in COPD is dynamic with inhaled corticosteroid treatment and reflects biological pathways associated with disease activity. van den Berge, Maarten; Steiling, Katrina; Timens, Wim; Hiemstra, Pieter S.; Sterk, Peter J.; Heijink, Irene H.; Liu, Gang; Alekseyev, Yuriy O.; Lenburg, Marc E.; Spira, Avrum; Postma, Dirkje S. // Thorax;Jan2014, Vol. 69 Issue 1, p14 

    Background A core feature of chronic obstructive pulmonary disease (COPD) is the accelerated decline in forced expiratory volume in one second (FEV1). The recent Groningen and Leiden Universities study of Corticosteroids in Obstructive Lung Disease (GLUCOLD) study suggested that particular...

  • Chronic Obstructive Pulmonary Disease.  // Current Medical Literature: Respiratory Medicine;2008, Vol. 22 Issue 2, p46 

    The article presents abstracts on chronic obstructive pulmonary disease (COPD) which include the prevention of COPD exacerbations by salmeterol/fluticasone propionate or tiotropium bromide, passive smoking exposure and risk of COPD among adults in China, and the effect of lung volume reduction...


Read the Article


Sign out of this library

Other Topics